Cosmetic glitter: questions to ask before formulation

Describe the precise intended use

Tell the supplier whether the project is a nail formulation, a rinse-off product, a leave-on product or another defined cosmetic use. State the destination market and the finished product format. Separate a design reference from an approved use: a photograph of glitter near an eye does not establish suitability. This detail helps the supplier understand the enquiry and helps your technical team identify which questions need answers before samples are shortlisted.

Review the finished material, including combinations

For the United States, FDA’s color-additive rules are tied to the substance and its intended use. FDA also explains that combining components can produce a pigment that is not approved for that use; its fact sheet specifically discusses holographic glitter as an example. Therefore, do not infer the status of a complete particle from the status of one component. Request the relevant identity and composition information for review.

Check use restrictions with the right source

FDA’s quick-reference tables distinguish eye-area, general and external cosmetic uses and link to the specific regulations. Use the table as a starting point, then check the applicable listing and restrictions. FDA’s eye-safety guidance also notes that some colors permitted in cosmetics generally are not permitted around the eye. Keep the review specific to the intended product and ingredient; this guidance does not establish approval or safety for any XUCAI glitter.

Request documents that can be traced to the sample

Create a document request using the exact sample or material code. Ask for the relevant composition declaration, technical information, safety documentation and available reports. Your assessor should determine which further evidence is needed for the market and finished formulation. Record who issued each document and which material it describes. A report bearing a laboratory name is only useful to the project when its specimen, scope and conclusion are relevant.

• Exact material identity, color, particle dimensions and batch reference.
• Relevant composition and colorant information for the proposed use.
• Applicable reports with a clear specimen, scope and date.
• Any restrictions or unresolved questions for the finished product assessor.

Run formulation trials after the document review

Use a controlled trial to compare the shortlisted material in the intended base. Record the loading, mixing procedure and any storage or conditioning steps. Assess the appearance and process behavior using methods set by your technical team. Keep the result separate from the regulatory review: a stable formula does not establish permitted use, while a document review does not prove that a particular formulation will remain visually acceptable.

Control the final specification and public wording

Once the project team accepts a candidate, connect the sample, specification and evidence in one purchasing record. Require a review when the material, color, application or destination market changes. Check website and packaging wording against that record before publication. Avoid treating a supplier-wide statement as a conclusion for every series. The purpose of a careful enquiry is to make the remaining decisions visible and assign them to the people responsible for the finished product.